Mode
Text Size
Log in / Sign up

AI chatbot interaction improves patient perceptions of pharmacist roles in a pilot study

AI chatbot interaction improves patient perceptions of pharmacist roles in a pilot study
Photo by Mohamed Nohassi / Unsplash
Key Takeaway
Consider AI chatbots as supplements to traditional patient education that encourage active participation.

This pilot randomized controlled trial involved 280 participants recruited via a crowdsourcing platform. The intervention group engaged with an AI chatbot (ChatGPT4-o) programmed with identical information to video content, while the comparator group received baseline control educational videos. Follow-up duration was not reported.

Significant differences emerged across treatment groups regarding willingness to seek pharmacist information, comfort asking questions, and awareness of medication monitoring. Perceptions improved in the AI chatbot group compared to controls, but absolute numbers and p-values were not reported. Sentiment analysis showed predominantly neutral or positive interactions, with neutral interactions occurring in n=252, positive in n=95, and few negative interactions.

Participants preferred detailed wh questions over yes/no questions, with wh questions recorded in n=170 and yes/no questions in n=103. Engagement depth positively correlated with improved perceptions, where deeper interaction led to better understanding. Safety data were not reported, and no adverse events or discontinuations were documented.

Limitations include the pilot study design and the crowdsourcing platform setup. Funding or conflicts of interest were not reported. AI-powered chatbots can serve as valuable supplements to traditional patient education, but implementation should focus on interfaces that encourage active participation. AI chatbots complement rather than replace human pharmacist interactions.

Study Details

Study typeRct
Sample sizen = 280
EvidenceLevel 2
PublishedJun 2026
View Original Abstract ↓
OBJECTIVE: To investigate how AI-powered chatbots influence patient perceptions of pharmacist roles compared to traditional educational methods and evaluate whether such technology can address knowledge gaps in pharmacy services. METHODS: A randomized controlled trial using a between-subject design was conducted through a crowdsourcing platform with 280 participants: baseline control (n = 82), educational video (n = 101), and AI chatbot interaction (n = 97). The survey assessed factors such as trust, comfort, and communication regarding pharmacist services using 7-point Likert scales. The AI chatbot utilized ChatGPT4-o, programmed with identical information to the video content to ensure experimental control. Participants in the chatbot group submitted an average of 3.03 prompts (range: 0-25). Statistical analysis included t-tests, ANOVA, and regression analysis of engagement metrics including word count and question types. RESULTS: Significant differences emerged across treatment groups in willingness to seek pharmacist information, comfort asking questions, and awareness of medication monitoring. Participants who actively engaged with the AI chatbot showed significantly improved perceptions of pharmacist roles. Sentiment analysis revealed predominantly neutral (n = 252) or positive (n = 95) interactions, with few negative engagements. Participants preferred detailed "wh" questions (n = 170) over yes/no questions (n = 103), with frequent inquiries about fundamental pharmacist roles. Regression analyses confirmed that engagement depth positively correlated with improved perceptions, suggesting deeper interaction led to better understanding of pharmacist capabilities beyond basic dispensing functions. CONCLUSION: Although both video and AI chatbot interventions improved patient knowledge, engagement level-not modality type-emerged as the critical determinant of outcomes. AI chatbots can effectively address knowledge gaps about pharmacist roles when patients actively participate in the learning process. PRACTICAL IMPLICATIONS: AI-powered chatbots can serve as valuable supplements to traditional patient education, particularly addressing limited understanding of pharmacist capabilities. Implementation should focus on interfaces that encourage active participation, as engagement emerged as the key determinant of educational effectiveness while complementing rather than replacing human pharmacist interactions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.